The TL-300 is a member of Tensys’ T-Line family of systems. Features include a tablet supported monitor that allows touch screen control and displays a patient’s key hemodynamic parameters.
“The TL-300 represents our continued commitment to delivering next generation, non-invasive, hemodynamic monitoring tools,” said Dr. Oliver Goedje, Tensys’ medical director, in the release. “This new system will not only enhance our current product offering, but will serve as a platform as we add cardiac output and additional hemodynamic parameters in the near future.”
Tensys Medical is headquartered in San Diego, Calif.
Related Articles on FDA Clearances:
Alphatec Spine Receives FDA Clearance for Anterior Cervical Interbody Device and MIS System
Dune Medical Receives FDA Clearance for MarginProbe Breast Cancer Surgery System
Medical Modeling Receives FDA Clearance for Virtual Surgical Planning System
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
